Telogen Effluvium
15
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
90.9%
+4.4% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists
Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.
Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study
Clinical Evaluation of a Nutraceutical Supplement (Olistic Women) for Hair Growth and Hair Loss in Human Volunteers
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium
BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
PAI-1 Expression in Non-scarring Hair Loss
COVID-19 Induced Telogen Effluvium
Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women
Evaluation of Tolerance and Trichological Efficacy of a Food Supplement